Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-18
2008-12-30
Morris, Patricia L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S274100
Reexamination Certificate
active
07470713
ABSTRACT:
The present invention provides compounds having formula Iand their use for the treatment of cancer.
REFERENCES:
patent: 6207687 (2001-03-01), Claiborne et al.
Vippagunta et al., “Crystalline Solids”, Advanced Drug Delivery Reviews 48 (2001) 3-26.
Guillory, “Generation of, etc.,” in Britain ed, Polymorphism in Pharmaceutical Solids, NY: Marcel Dekker, Inc., 1999 183-226.
Balant, Metabolic Considerations, etc., in Wolff ed, Burger's Medicinal Chemistry and Drug Discovery, 1995, NY: John Wiley & Sons, Inc.
Marinier Anne
Martel Alain
Roy Stephan
Bristol--Myers Squibb Company
Gibbons Maureen S.
Liu Hong
Morris Patricia L
LandOfFree
Imidazole based kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole based kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole based kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4020409